Leading Virtual Care Platform Conversa Health Raises $12 Million as COVID-19 Accelerates the Need for Digital Health
SK Biopharmaceuticals has begun bookbuilding for its up to W959.3bn ($804.9m) IPO. It is set to be South Korea’s first listing in 2020.
Spanish biotechnology-dedicated venture capital firm Ysios Capital has raised €155m for its third fund, Ysios BioFund III, which has a final target of €200m.
Cortec Group has sold its remaining equity interest in YETI, a designer and marketer of ice chests and coolers. Cortec acquired YETI in partnership with the company’s founders, Roy and Ryan Seiders, in June 2012.
Kinderhook has acquired Paramount Specialty Pharmacy and PharmBlue Holdings and will combine them with its existing pharmacy companies Long’s Drugs and PharMedQuest. The new merged platform will operate under the name of Avita Pharmacy. Kinderhook
Alibaba Health Information Technology navigated concerns around its lofty valuations to pull off Hong Kong’s largest primary follow-on in five years, raising HK$10bn ($1.29bn) after boosting the size of the deal. The transaction closed with
Advanced therapies-focused venture capital firm 4BIO Capital has picked up a strategic investment in its newest fund from specialist pharma and biotech business Kyowa Kirin.
Mainland-based firms OcuMension Therapeutics and Immunotech Biopharm sealed their Hong Kong IPOs at the top of guidance, riding on support from both institutional and retail investors.
Kinderhook Industries has acquired Original One Auto Parts. This acquisition is the firm’s 86th acquisition in the automotive aftermarket. Dallas-headquartered Original One Parts is a provider of recycled, refinished, and certified original equipment manufacturer auto parts
Francisco Partners has held a final closing of three funds, two equity funds and one credit fund, with an aggregate $10 billion of capital. The three new funds are Francisco Partners VI LP with $7.45
The bank, run by Wall Street dealmaker Ken Moelis, has hired Philippe Gallone as a managing director
OrbiMed has led a $70m funding round for biopharmaceutical company Mereo BioPharma.
Laxman Pai, Opalesque Asia: Petra Capital Partners has picked up $208m for the final close of its fourth growth fund Petra Growth Fund IV (PGF IV). The fund targets healthcare, business, and technology-enabled services ...Article
Arcline Investment Management has acquired Glebar Company from its management shareholders led by Chairman and former CEO Adam Cook. Glebar manufactures and services micromachining, centerless grinding and electrochemical grinding systems used in the production of
The US-based firm invested in the consumer healthcare company, betting on growing consumer appetite for health supplements ordered online
